1-10 of 10
A. Alegre
Close
Sort by
Journal Articles

Laser Transmyocardial Revascularization (TMR) Combined with Autologous Bone Marrow Cells for Diffuse Coronary Disease: Immunophenotype Analysis and Preliminary Clinical Results in 14 Cases

A. Alegre, B. Aguado, M. Alfonso-Pérez, C. Muñoz, M. Ortiz de Landázuri, F. Sánchez-Madrid, C. Cámara, F. Lara, J. Duarte, G. Reyes
Journal: Blood
Blood (2008) 112 (11): 4442.
https://doi.org/10.1182/blood.V112.11.4442.4442
Published: 2008
Journal Articles

Efficacy of Lenalidomide in Different Clinical Settings in Patients with Relapsed or Progressive Multiple Myeloma: Updated Analysis of 111 Cases of the Spanish Compassionate Use Program

A. Alegre, B. Aguado, P. Giraldo, P. Cánovas, A. Ibáñez, I. Castillo, M. Blanes, E. Ríos, J.N. Rodríguez, L. Palomera, MT Hernández, A. Oriol, E. Sancho, C. Menchaca, J. Vercher, AP González, M.J. Arilla, G. Ramírez, R. Pérez, A. Asensio, Javier De la Serna, MD, S. Osorio, C. Aguilar, V. Ansó, J.M. Calvo, M. Casanova, M. Fuertes, J.L. Guzmán, L. López, A. López, J.L. Olalla, J.M Hernández, P. Ríos, L. Villalon, I. García, A. García, S. Larregla, F. Lara, J.L. Lahuerta
Journal: Blood
Blood (2008) 112 (11): 5199.
https://doi.org/10.1182/blood.V112.11.5199.5199
Published: 2008
Journal Articles

A Prospective, Observational Study of the Effectiveness and Safety of a Weekly Fixed Dose of Darbepoetin alfa with Current Practice Iron Management for the Treatment of Chemotherapy-Induced Anemia (CIA): A Subanalysis in Patients (pts) with Lymphoproliferative Malignancies (LPM).

A. Alegre, A. Salar, I. Roig, J.C. Bermejo, A. Palacios, R. de Paz, R. Arranz, A. Fernández, R. Calzada, P. Iturralde, On Behalf of the AMG-DAR-2002-01 Study Group
Journal: Blood
Blood (2005) 106 (11): 3715.
https://doi.org/10.1182/blood.V106.11.3715.3715
Published: 2005
Journal Articles

Epidemiology of Multiple Myeloma in Spain: An Analytic Review.

A. Alegre, F. Lara, R. Gabriel, B. Aguado, L.M. Sánchez, S. Damiano, J. San Miguel, J. Blade, J.J. Lahuerta, A. Sureda, J. García-Laraña, J. Díaz Mediavilla, F. de Arriba, J. de la Rubia, F. Prosper, J. Bargay, R. Martínez, C. Martinez-Chamorro, M.T. Hernández, F. Hernández-Navarro, J. Besalduch, M. González-López, J. Petit, C. Solano, L. Hernández-Nieto, J. Baro, R. Parody, R. Cabrera, E. Flores, M.T. Bernal, J.F. Tomás, J.M. Fernández-Rañada
Journal: Blood
Blood (2005) 106 (11): 5089.
https://doi.org/10.1182/blood.V106.11.5089.5089
Published: 2005
Journal Articles

A Weekly Dose of Pegylated Interpheron alpha-2b (Pegintron®) as Maintenance Treatment after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Multiple Myeloma (MM): Preliminary Experience.

A. Alegre, B. Aguado, J. San Miguel, J. Garcia-Laraña, F. Lara, J.J. Lahuerta, B. Navas, J. Loscertales, A. Durán, A. García, B. Iñigo, E. Moreno, J.M. Fernández-Rañada
Journal: Blood
Blood (2005) 106 (11): 5174.
https://doi.org/10.1182/blood.V106.11.5174.5174
Published: 2005
Journal Articles

Reduced Intensity Conditioning Unrelated Transplant Plus Cyclosporine and MMF as GVHD Prophylaxis: Results of a Prospective Study.

J.A. Perez-Simon, MD, PhD, R. Martino, MD, PhD, R. de la Camara, MD, PhD, J. Perez de Oteiza, MD, PhD, J.M. Moraleda, MD, PhD, M. Diez-Campelo, MD, PhD, A. Sureda, MD, PhD, A. Alegre, MD, PhD, J. Sierra, MD, PhD, J.F. San Miguel, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5312.
https://doi.org/10.1182/blood.V106.11.5312.5312
Published: 2005
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma (MM) Patients.

M.V. Mateos, M. Hernández, J. Díaz Mediavilla, L. Palomera, M.J. Moro, J. Hernández, J.J. Lahuerta, J. De la Rubia, M.J. Terol, A. Sureda, J. Bargay, F. Arriba, A. Alegre, P. Rivas, J. García-Laraña, J.M. Ribera, D. Carrera, J. Bladé, F. Prósper, D.L. Esseltine, H. van de Velde, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2005) 106 (11): 786.
https://doi.org/10.1182/blood.V106.11.786.786
Published: 2005
Journal Articles

Influence of Age on Survival after a Tandem Hematopoietic Stem Cell Transplantation Procedure in Patients with Multiple Myeloma: Results of the Prospective GEM-2000 Protocol.

A. Sureda, J. Blade, J.J. Lahuerta, J. de la Rubia, R. Martinez, D. Carrera, J. Garcia-Laraña, A. Alegre, M. Hernandez, C. Rivas, J.M. Ribera, M.J. Peñarrubia, L. Palomera, F. Prosper, F. de Arriba, A. Leon, E. Abella, B. Hernandez-Ruiz, F. Casado, J.C. Garcia-Ruiz, J. Besalduch, F.J. Fernandez-Calvo, A. Touchard, J. San Miguel, for the Spanish Group of Multiple Myeloma (MM)
Journal: Blood
Blood (2004) 104 (11): 930.
https://doi.org/10.1182/blood.V104.11.930.930
Published: 2004
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.

M.V. Mateos, Joan Blade, J. Diaz Mediavilla, J.J. Lahuerta, M.J. Terol, J. Hernández, M.J. Moro, J. Bargay, J.M. Ribera, J. de la Rubia, A. Sureda, D. Carrera, F. de Arriba, L. Palomera, M. Hernández, J. García Laraña, A. Alegre, F. Prosper, P. Rivas, D.L. Esseltine, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2004) 104 (11): 3462.
https://doi.org/10.1182/blood.V104.11.3462.3462
Published: 2004
Journal Articles

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

BB Bjorkstrand, P Ljungman, H Svensson, J Hermans, A Alegre, J Apperley, J Blade, K Carlson, M Cavo, A Ferrant, AH Goldstone, A de Laurenzi, I Majolino, R Marcus, HG Prentice, K Remes, D Samson, A Sureda, LF Verdonck, L Volin, G Gahrton
Journal: Blood
Blood (1996) 88 (12): 4711–4718.
https://doi.org/10.1182/blood.V88.12.4711.bloodjournal88124711
Published: 1996